Special Issues

Special Issue Title: Cardiovascular Biomarkers: Prognostic Markers and Indicators of Treatment Efficacy

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 March 2022


Special Issue Editor

Guest Editor


Prof. Wayne L. Miller, MD, PhD 

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Website | E-Mail

Interests: Acute and chronic heart failure and acute coronary syndromes


Special Issue Information

Dear Colleagues,


The identification, evolution and clinical use of biomarkers in cardiovascular medicine, particularly in heart failure, have advanced dramatically over the past few decades. Progress in biomarker research related to cardiovascular disease has led to more sensitive screening methods, a greater emphasis on early detection and the establishment of clinical diagnoses, provided prognostic information and improved the ability to monitor the effectiveness of therapeutic interventions. Importantly, this has resulted in more favorable patient outcomes. However, the development of novel biomarkers to investigate physiologic and pathophysiologic processes in cardiovascular disease remains an important area of ongoing clinical research. Further, the reimaged use of established biomarkers is being explored with many new developments yet to come. While this area is vast in the scope of biomarkers that are currently being used or studied in the arena of cardiovascular medicine, this special issue in “Reviews in Cardiovascular Medicine” will focus on the prognostic and therapy-related monitoring roles of various key biomarkers and their incremental benefit and utility for clinical practice.  We hope this discussion will provide our readers with new insights and affirm information on biomarkers and their use in cardiovascular medicine.

Prof. Wayne L. Miller

Guest Editor

 

Manuscript Submission Information

Manuscripts should be submitted online at https://rcm.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reviews in Cardiovascular Medicine is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1950. Submitted papers should be well formatted and use good English.


Keywords

Biomarkers; Cardiovascular diseases; Prognosis; Treatment Response; Novel Biomarkers; Clinical Research; Pathophysiology


Share This Special Issue

     


Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 22, Issue 3